Scarica l'app Stockscreener
0.8872
3.04%
-0.0278
Dopo l'orario di chiusura:
.87
-0.0172
-1.94%
Precedente Chiudi:
$0.915
Aprire:
$0.93
Volume 24 ore:
362.04K
Relative Volume:
0.27
Capitalizzazione di mercato:
$74.93M
Reddito:
$153.73M
Utile/perdita netta:
$-106.79M
Rapporto P/E:
-0.4984
EPS:
-1.78
Flusso di cassa netto:
$-115.93M
1 W Prestazione:
+16.74%
1M Prestazione:
+10.17%
6M Prestazione:
-56.51%
1 anno Prestazione:
-79.30%
Intervallo 1D:
$0.8706
$0.9563
Intervallo di 1 settimana:
$0.76
$1.01
Portata 52W:
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
Nome
Sutro Biopharma Inc
Settore
Industria
Telefono
650-392-8412
Indirizzo
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Confronta STRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.8872 | 77.28M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-03-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-05-08 | Iniziato | BofA Securities | Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-06 | Iniziato | Oppenheimer | Outperform |
| 2023-03-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Ripresa | Wells Fargo | Overweight |
| 2021-06-18 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-09-02 | Iniziato | Jefferies | Buy |
| 2020-07-16 | Iniziato | Wells Fargo | Overweight |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-10-07 | Iniziato | BTIG Research | Buy |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2019-04-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-10-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-10-22 | Iniziato | Piper Jaffray | Overweight |
| 2018-10-22 | Iniziato | Wedbush | Outperform |
Mostra tutto
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Is Sutro Biopharma Inc. stock overvalued or undervaluedFree Stock Market Forecast Reports - jammulinksnews.com
Does Sutro Biopharma Inc. stock perform well during market downturnsAccelerated wealth expansion - jammulinksnews.com
How strong is Sutro Biopharma Inc. company’s balance sheetTriple-digit returns - jammulinksnews.com
What are the latest earnings results for Sutro Biopharma Inc.Explosive portfolio gains - jammulinksnews.com
What institutional investors are buying Sutro Biopharma Inc. stockUnstoppable investment returns - jammulinksnews.com
What are the technical indicators suggesting about Sutro Biopharma Inc.High-yield investments - jammulinksnews.com
What makes Sutro Biopharma Inc. stock price move sharplyGet timely alerts on market movers - jammulinksnews.com
Key External Factors That Drive Sutro Biopharma Inc. Stock Price MovementsMomentum Buy Alert - Newser
Why Sutro Biopharma Inc. stock attracts strong analyst attentionParabolic Move Ideas - Newser
What analysts say about Sutro Biopharma Inc. stockFree Capital Allocation Plans - PrintWeekIndia
Sutro Biopharma Inc. Stock Analysis and ForecastFree Capital Growth Strategies - Autocar Professional
How Sutro Biopharma Inc. stock reacts to Fed policy changesUnrivaled growth potential - jammulinksnews.com
Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely - Yahoo Finance
What drives Sutro Biopharma Inc. stock priceExplosive capital gains - jammulinksnews.com
Sutro Biopharma partners with FDA to develop ADC reference materials By Investing.com - Investing.com Canada
Sutro Biopharma partners with FDA to develop ADC reference materials - Investing.com Australia
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates - The Manila Times
FDA Selects Sutro Biopharma's Revolutionary Platform to Shape Future of Cancer Drug Development - Stock Titan
Is Sutro Biopharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
what makes sutro biopharma inc. stock price move sharplyReal Time Alert Service - Newser
How Sutro Biopharma Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser
Sutro Biopharma Inc Azioni (STRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):